BioMed Research International
Volume 2014 (2014), Article ID 547986, 13 pages
http://dx.doi.org/10.1155/2014/547986

Review Article

Molecular and Cellular Basis of Autosomal Recessive Primary Microcephaly

Marine Barbelanne1,2 and William Y. Tsang1,2,3

¹Institut de Recherches Cliniques de Montréal, 110 avenue des Pins Ouest, Montréal, QC, Canada H2W 1R7
²Faculté de Médecine, Université de Montréal, Montréal, QC, Canada H3C 3J7
³Division of Experimental Medicine, McGill University, Montréal, QC, Canada H3A 1A3

Received 16 July 2014; Revised 18 September 2014; Accepted 18 September 2014; Published 8 December 2014

Academic Editor: Saulius Butenas

Copyright © 2014 Marine Barbelanne and William Y. Tsang. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Autosomal recessive primary microcephaly (MCPH) is a rare hereditary neurodevelopmental disorder characterized by a marked reduction in brain size and intellectual disability. MCPH is genetically heterogeneous and can exhibit additional clinical features that overlap with related disorders including Seckel syndrome, Meier-Gorlin syndrome, and microcephalic osteodysplastic dwarfism. In this review, we discuss the key proteins mutated in MCPH. To date, MCPH-causing mutations have been identified in twelve different genes, many of which encode proteins that are involved in cell cycle regulation or are present at the centrosome, an organelle crucial for mitotic spindle assembly and cell division. We highlight recent findings on MCPH proteins with regard to their role in cell cycle progression, centrosome function, and early brain development.

1. Introduction

Autosomal recessive primary microcephaly (MCPH) is a rare condition associated with developmental anomaly of the brain. This neurodevelopmental disorder is characterized by a reduced occipitofrontal head circumference (OFC) at birth to at least 2-3 standard deviations below the mean for sex, age, and ethnicity, a slower than average growth in OFC after birth, and prenatal onset as early as the second trimester of gestation [1–6]. MCPH patients possess a small brain with simplified gyri and exhibit varying degrees of intellectual disability; however, the architecture of the brain in general is not grossly affected. In some instances, MCPH is associated with additional clinical features, including short stature, mild seizures, or skeletal abnormalities, and shows genetic and clinical overlap with related disorders such as Seckel syndrome (SCKL; OMIM 210600, 606744, 608664, 613676, 613823, 614728, 614851, 615807), Meier-Gorlin syndrome (OMIM 224690, 613800, 613804), and microcephalic osteodysplastic dwarfism (OMIM 210710, 210720, 210730) [7–12]. Although MCPH was traditionally distinguished from other disorders by height, short stature is no longer a distinguishing feature. Furthermore, it is now known that mutations in the same gene can cause MCPH and SCKL. In light of these observations, it is tempting to speculate that there must be a considerable overlap between the pathological mechanisms underlying MCPH and related disorders.

2. MCPH Loci and Brain Development

To date, twelve genetic loci (MCPH-MCPH12) are implicated in MCPH (Table 1). The majority of mutations reported in these genes are frameshift or nonsense mutations leading to truncated proteins that are nonfunctional (please refer to references in Table 1). Perhaps not surprisingly, MCPH gene products are shown to be highly expressed in neuroepithelial or neuroprogenitor cells during early brain development [13–17]. Brain size at birth is primarily dependent on the ability of neuroprogenitor cells to proliferate and self-renew [9, 10, 18, 19]. While symmetrical division of a neuroprogenitor cell results in the generation of two identical neuroprogenitor cells (thereby increasing the progenitor pool), asymmetrical division leads to the production of one progenitor cell (thereby maintaining the progenitor pool) and a committed precursor, which eventually undergoes migration and differentiates into neurons [20, 21]. Conceivably, any perturbation that upsets the balance between symmetric and asymmetric division can drastically reduce the number of neuroprogenitor and neuronal cells, leading to reduced brain size [10]. Although such a mechanism is appealing, it is important to note that additional mechanisms, including cell proliferation defects, enhanced cell death/apoptosis, abnormal neuronal migration and/or differentiation, can also impair brain development and contribute to the development of MCPH [10]. Interestingly, a significant number of MCPH proteins identified thus far are found to be associated with the centrosome [15, 16, 22–29], an organelle intimately connected with cell division, suggesting that proper cell cycle control could play an important role in neurogenesis.

Table 1: Gene table: autosomal recessive primary microcephaly (MCPH).

Gene
Locus
Gene product
References (gene and/or locus)
OMIM

MCPH1 MICROCEPHALIN
MCPH1
MICROCEPHALIN
[40]
607117

WDR62 (WD repeat-containing protein 62)
MCPH2
WDR62
[169]
613583

CDK5RAP2 (CDK5 regulatory subunit-associated protein 2)
MCPH3
CDK5RAP2
[170]
608201

CASC5 (cancer susceptibility candidate 5)
MCPH4
CASC5
[171]
609173

ASPM (abnormal spindle-like microcephaly-associated protein)
MCPH5
ASPM
[172]
605481

CENPJ (centromere protein J)
MCPH6
CENPJ
[15]
609279

STIL (SCL/TAL1-interrupting locus)
MCPH7
STIL
[25]
181590

CEP135 (centrosomal protein of 135 kDa)
MCPH8
CEP135
[26]
611423

CEP152 (centrosomal protein of 152 kDa)
MCPH9
CEP152
[27]
613529

ZNF335 (zinc finger protein 335)
MCPH10
ZNF335
[156]
610827

PHC1 (polyhomeotic-like protein 1)
MCPH11
PHC1
[157]
602978

CDK6 (cyclin-dependent kinase 6)

CDK6
[29]
603368

3. Centrosome Structure and Function

The centrosome is the major microtubule-organizing center in mammalian cells and modulates diverse cellular processes such as cell cycle progression, cell shape, polarity, adhesion and motility, cilia assembly, DNA damage response, intracellular transport, positioning of cellular organelles, mitotic spindle formation, positioning and orientation, and genome stability [30–35]. This organelle is composed of a pair of centrioles, a mother and a daughter, surrounded by an amorphous pericentriolar matrix (PCM) (Figure 1). Centrioles, cylindrical structures consisting of nine triplets of stabilized microtubules, organize the PCM, which in turn nucleates and anchors cytoplasmic microtubules necessary for mitotic spindle assembly and chromosome segregation. Centrosome number, morphology, and function are tightly regulated during the cell cycle [36–39]. A cell in the G1 phase has one centrosome. Centrosome duplication occurs once in the S phase and entails the synthesis of two new centrioles or procentrioles adjacent to the existing centrioles. At the G2/M transition, the duplicated centrosomes separate and migrate to opposite poles of the cell, and through a process known as centrosome maturation, additional proteins are recruited to the PCM to increase its microtubule-nucleating and -anchoring capacity essential for cell division. Defects in centrosome duplication and/or maturation are known to compromise cell cycle progression and cell division, resulting in aneuploidy, cell cycle arrest, cell death, and/or uncontrolled cell growth. Indeed, centrosome dysfunction has been linked to a wide variety of human diseases including MCPH, but how exactly does it impede the cell cycle and affect brain development at the mechanistic level? In the next section, we will highlight the current status of our knowledge on the role of each MCPH gene product in cell cycle regulation, centrosome function, and neurogenesis.

Figure 1: Centrosome structure. Centrosomes are small organelles composed of two perpendicular centrioles (orange cylinders), a mother and a daughter, linked together by interconnecting fibres (dark green). The centrioles are surrounded by an amorphous pericentriolar matrix (dotted orange background) involved in the nucleation and anchoring of cytoplasmic microtubules. Contrary to the daughter centriole, the mother centriole possesses distal (purple) and subdistal (blue) appendages necessary for cilia assembly and microtubule anchoring, respectively.

4. MICROCEPHALIN

MCPH1/MICROCEPHALIN is the first disease gene identified for MCPH and it encodes MICROCEPHALIN, a multifunctional protein that participates in various cellular processes [13, 40, 41]. MICROCEPHALIN possesses three BRCT (BRCA1 C-terminal) domains commonly found in proteins involved in cell cycle control, DNA damage response, and DNA repair [42]. Indeed, it functions to recruit the chromatin remodelling complex SWI-SNF (switch/sucrose nonfermentable) to DNA lesions and interacts with the E2F1 transcription factor to regulate genes involved in DNA repair and apoptosis [43–45]. MICROCEPHALIN also associates with CONDENSIN II, a protein involved in chromosome condensation, perhaps explaining why a loss of MICROCEPHALIN function triggers early cell cycle progression and premature chromosome condensation [46, 47]. Besides its nuclear localization, MICROCEPHALIN also localizes to the centrosome throughout the cell cycle and interacts with PERICENTRIN, a PCM component critical for centrosome maturation, to control the localization of CHK1 (checkpoint kinase 1) to the centrosome [22, 48, 49]. In the absence of MICROCEPHALIN, CHK1 is mislocalized and cannot phosphorylate and inactivate CDC25B (cell division cycle 25B), thereby triggering premature CDK1 (cyclin-dependent kinase 1) activation and early mitotic entry. Interestingly, PERICENTRIN is also mislocalized from the centrosome in the absence of MICROCEPHALIN, suggesting that the latter recruits the former to the centrosome. Although two mouse models of Mcph1 show no obvious brain phenotype [50, 51], a conditional knock-out causes untimely entry into mitosis, mitotic spindle misorientation, and a premature switch of neuroprogenitors from symmetric to asymmetric division, resulting in primary microcephaly (Table 2) [49, 52]. Interestingly, silencing Cdc25b is sufficient to rescue these phenotypes, suggesting that proper mitotic entry and progression are needed to maintain a balance between neuroprogenitor proliferation and neuronal differentiation.

Table 2: Animal models of MCPH.

Gene
Model
Method
Phenotype

MCPH1 MICROCEPHALIN
Mouse
Knock-out (deletion of exon 2)
Genomic instability, growth retardation, male infertility, and increased radiation sensitivity

Mouse
Knock-out (gene trap)
Shorter life span, improper chromosome condensation

Mouse
Conditional knock-out (recombination)
Specific reduction of the cerebral cortex at birth

Fly
Knock-out (p-element excision)
Abnormal spindles during embryonic cell cycle

WDR62
Rat
shRNA knock-down
Premature differentiation of neuroprogenitors into neurons

Zebrafish
Morpholino-mediated knock-down
Reduction in head and eye size

Mouse
Knock-out (deletion of the WDR62 locus)
Reduced brain size

CDK5RAP2
Fly
Knock-out (chemical mutagenesis)
Disconnection between centrosome and PCM

Mouse
shRNA knock-down
Premature neuronal differentiation

Hertwig’s anemia mouse
Inversion of exon 4
Reduced brain size

ASPM
Zebrafish
Morpholino-mediated knock-down
Reduction in head and eye size

Mouse
siRNA knock-down
Premature differentiation of telencephalic neuroprogenitor cells

Mouse
Knock-out (removal of exons 2 and 3)
Reduced brain size

Mouse
Knock-out (gene trap)
Mild microcephaly, massive loss of germ cells

Fly
Mutagenesis (x-irradiation)
Spindle positioning defects, increased apoptosis

CENPJ
Mouse
Conditional knock-out (truncated mRNA)
Intrauterine growth retardation

Fly
Knock-out (transposon insertion)
Loss of centrioles, abnormal spindle

Worm
siRNA knock-down
Loss of centrioles, abnormal centrosome size/organization

STIL
Mouse
Knock-out (removal of exons 3 to 5)
Embryonic lethality

Zebrafish
Morpholino-mediated knock-down
Embryonic lethality

CEP135
Fly
Knock-out (transposon insertion)
Abnormal centrioles, immotile cilium

Alga
Insertion mutagenesis
Abnormal centrioles, abnormal cell division, and slow growth

Protozoa
siRNA knock-down
Abnormal centrioles

CEP152
Fly
Chemical mutagenesis
Defective centrosomes, no zygotic division

Zebrafish
Morpholino-mediated knock-down
Ciliary defects

ZNF335
Mouse
shRNA knock-down
Impaired progenitor cell proliferation

Mouse
Knock-out (removal of promoter and exons 1 and 2)
Severely reduced cortical size

Mouse
Knock-out (gene trap insertion)
Embryonically lethal

CDK6
Mouse
Knock-out (removal of 1st coding exon)
Viable, develop normally, hematopoiesis slightly impaired

5. WDR62 (WD Repeat-Containing Protein 62)

WDR62 is the second most frequently mutated gene in MCPH, accounting for about 10% of cases [16, 23, 53, 54]. Its encoded protein product possesses several WD40 (beta-transducin repeat) domains that mediate protein-protein interactions. WDR62 is predominantly a nuclear protein during interphase and accumulates at the spindle poles during mitosis [16, 55, 56]. The primary function of WDR62 is to preserve centrosome/spindle pole integrity after bipolar spindle formation, since a loss of this protein leads to the dispersal of PCM components PERICENTRIN, γ-TUBULIN, and CDK5RAP2 (CDK5 regulatory subunit-associated protein 2) (these three PCM proteins are known to interact with each other) from metaphase centrosomes [55, 56]. In addition, WDR62 is a substrate of c-Jun N-terminal kinase (JNK), active at the centrosome during mitosis, and phosphorylation of WDR62 by JNK is required for mitotic spindle organization [55, 57]. Depletion of either Wdr62 (shRNA knock-down, Table 2) or Jnk induces spindle misorientation and triggers the asymmetric division of neuroprogenitors in the rat telencephalon, leading to their premature differentiation into neurons [58]. In another study, morpholino-mediated knock-down of wdr62 or two other microcephaly proteins, aspm (abnormal spindle-like microcephaly-associated protein) and sil (STIL in human; SCL/TAL1-interrupting locus), in zebrafish causes a significant reduction in head and eye size [59]. This phenotype is believed to be due to a failure in metaphase progression, leading to increased cell death [59]. Likewise, neuroprogenitor cells of mice deficient in Wdr62 exhibit spindle assembly checkpoint activation, delayed mitotic progression, and cell death, resulting in reduced brain size (Table 2) [60]. Finally, lymphoblastoid cells derived from patients with compound heterozygous mutations in WDR62 exhibit mitotic spindle defects as well as abnormal centrosomal protein localization [56]. Mechanistically, WDR62 physically and genetically interacts with AURORA A [60], a serine/threonine protein kinase that controls centrosome maturation, spindle formation, and mitotic progression. AURORA A is a PCM protein, and its targeting to and subsequent activation at the mitotic spindle are dependent on another centrosomal protein CEP192 (centrosomal protein of 192 kDa) (discussed later) [61]. Thus, WDR62 appears to control the fate of neuroprogenitors cells partially through AURORA A.

6. CDK5RAP2 (CDK5 Regulatory Subunit-Associated Protein 2)

By virtue of its ability to interact with γ-TUBULIN, CDK5RAP2 is a PCM protein crucial for microtubule nucleation [62, 63]. Depletion of CDK5RAP2 delocalizes γ-TUBULIN from centrosomes, thereby preventing centrosomal microtubule formation. Another PCM component, PERICENTRIN, also physically interacts with CDK5RAP2, and recruitment of the latter to the centrosome depends on the former but not vice versa [64–66]. In addition to its role in PCM regulation, CDK5RAP2 is also required for centriole and centrosome cohesion, and ablation of this protein induces unscheduled centriole splitting, leading to amplified centrosomes and multipolar spindles [67, 68]. Furthermore, CDK5RAP2 has the capacity to bind DNA and functions as a transcription activator to regulate the expression of two spindle checkpoint genes, BUBR1 (budding uninhibited by benzimidazole-related 1) and MAD2 (mitotic arrest deficient 2) [69]. Recently, the role of Cdk5rap2 in neurogenesis was examined in mice. Consistent with the functional relationship between Cdk5rap2 and Pericentrin, knock-down of either protein depletes the neural progenitor pool and triggers cell cycle exit, leading to premature neuronal differentiation without substantial apoptosis in the developing mouse neocortex of an in utero electroporation model (Table 2) [70]. In contrast, a different study showed that although the Hertwig’s anemia mouse exhibits microcephaly, most neuroprogenitor cells undergo apoptosis instead of differentiating into neurons after exiting the cell cycle abruptly (Table 2) [71]. Thus, CDK5RAP2 could play a role in neuroprogenitor cell death and neuronal differentiation.

7. CASC5 (Cancer Susceptibility Candidate 5)

CASC5 is among the most recently identified genes responsible for MCPH [72]. Unlike most MCPH proteins which localize to centrosomes, CASC5 is a kinetochore scaffold protein required for the proper attachment of chromatin to the mitotic apparatus [73]. It also associates with BUB1 (budding uninhibited by benzimidazoles 1) and BUBR1 to control the spindle assembly checkpoint. Depletion of this protein induces chromosome misalignment and accelerates entry into mitosis, a phenotype reminiscent of MICROCEPHALIN loss [74–77]. Future experiments, including the use of animal models, are needed to further delineate the molecular and cellular function of CASC5 and to define its role in neurogenesis.

8. ASPM (Abnormal Spindle-Like Microcephaly-Associated Protein)

Mutations in the ASPM gene constitute the most common cause of MCPH and accounts for about 25–50% of cases [6, 10, 14, 78–90]. ASPM contains a microtubule-binding domain, two calponin homology domains commonly found in cytoskeletal proteins, and multiple IQ calmodulin-binding motifs. This protein may be required for the maintenance of centrosome/spindle integrity because, like WDR62, it is mostly concentrated in the nucleus and only relocates to the spindle pole during mitosis [24]. Furthermore, CALMODULIN, a calcium-binding protein known to interact with PERICENTRIN and ASPM, also exhibits strong staining at the spindle poles [91]. Localization of ASPM to the spindle pole is greatly diminished in fibroblasts derived from a patient carrying a homozygous ASPM mutation [92]. Depletion of ASPM in human cells affects spindle positioning and alters the division symmetry from symmetrical to asymmetrical, leading to cytokinesis failure [92]. Similarly, ablation of Aspm enhances asymmetric cell division and premature differentiation of mouse telencephalic neuroprogenitor cells without causing cell cycle arrest (Table 2) [93]. Likewise, aspm mutant flies display spindle-positioning defects, in addition to increased apoptosis [94, 95]. In contrast, mutant mice (Aspm ¹⁻²⁵ and Aspm ¹⁻⁷) expressing truncated proteins show no major alteration of cleavage plane orientation but are still microcephalic [96]. Taken together, ASPM may have additional function besides spindle positioning and division axis orientation critical for symmetric cell division. Of note, although Aspm mutant mice and flies exhibit microcephaly, these animals also have impaired fertility due to a massive loss of germ cells [96–99]. These observations, coupled with findings that ASPM and MICROCEPHALIN are highly upregulated in different types of cancer [100–103], suggest that these two proteins could also positively regulate cell proliferation in multiple cell types.

9. CENPJ (Centromere Protein J)

A handful of core centrosomal components, including four microcephaly proteins CENPJ, STIL, CEP135 (centrosomal protein of 135 kDa), and CEP152 (centrosomal protein of 152 kDa), were recently identified as essential regulators of centriole duplication [104–106]. Centriole duplication is thought to occur in several sequential steps, wherein CEP152 and CEP192 first interact with each other to recruit polo-like kinase 4 (PLK4) to the site of centriole assembly [107–111]. This event is followed by the recruitment of SAS-6 (spindle assembly abnormal protein 6 homolog) and STIL, proteins that dictate the nine-fold radial symmetric arrangement of microtubules in centrioles, and finally CENPJ, to new centrioles [106, 112–117]. CENPJ is known to interact with STIL, CEP135, and CEP152, and in addition, possesses the capacity to bind microtubules and to associate with CEP120 (centrosomal protein of 120 kDa) and SPICE1 (spindle and centriole associated protein 1), two proteins essential for centriole elongation [110, 111, 118–123]. Indeed, CENPJ is specifically involved in the elongation step of centriole duplication, and depletion of this protein leads to the formation of nascent centrioles that fail to reach full length, whereas overexpression promotes the formation of elongated centrioles [124–126]. Both moderate and excessive centriole elongations are detrimental to cells, causing loss of centrosome integrity and formation of multipolar spindles [126, 127]. In addition to its role in centriole biogenesis, CENPJ also interacts with several PCM components to regulate the size of the PCM [128–130]. CENPJ was also found to play an important role in controlling the prefrontal cortex development in human [131]. Targeted inactivation of Cenpj in mice recapitulates many of the clinical features of MCPH and SCKL, including mitotic failure and massive cell death during embryonic development (Table 2) [132]. Notably, of the 12 MCPH proteins identified to date, only deficiencies in CENPJ and CEP152 are known to cause both MCPH and SCKL, the latter of which is a disorder traditionally characterized by short stature [132, 133]. Since CENPJ regulates several aspects of centrosome function, a loss of this protein may lead to deficits in multiple cellular pathways which act together to cause dwarfism.

10. STIL (SCL/TAL1-Interrupting Locus)

STIL is a centrosomal protein localized to newly synthesized centrioles [118, 134, 135]. Immediately after PLK4 is recruited by CEP152 and CEP192, SAS-6 and STIL are brought to the site of centriole assembly. SAS-6 directly interacts and forms a complex with STIL, and these two proteins resemble each other in many ways in terms of functionality, subcellular localization pattern, and expression levels during the cell cycle [118, 134, 135]. Ablation of one protein causes mislocalization of the other, suggesting that STIL and SAS-6 are mutually dependent for their localization to centrioles. Moreover, upregulation of STIL induces the formation of multiple nascent centrioles around the parental centriole, mimicking the phenotype of SAS-6 or PLK4 overexpression [106, 136, 137]. STIL appears to be important for spindle positioning and mitotic progression [59, 138, 139]. Inactivation of sil in zebrafish or STIL in mice results in embryonic lethality (Table 2), indicating that this protein may play additional roles beyond brain development [139, 140].

11. CEP135 (Centrosomal Protein of 135 kDa)

As an important regulator of centrosome biogenesis, CEP135 is a centriolar protein that associates with SAS-6 and CENPJ [123, 141, 142]. The precise relationship between CEP135 and SAS-6 is not completely clear at this point, although these proteins do not appear to depend on each other for localization to the centriole. On the other hand, CEP135 recruits CENPJ to centrioles, and not vice versa, indicating that CEP135 likely functions upstream of CENPJ [123]. Furthermore, in contrast to the loss of PLK4, SAS-6, or STIL, which completely suppresses centriole duplication, ablation of CEP135 results in a less severe phenotype with shorter centrioles and atypical centriolar structure [123, 143]. By the same token, abnormal centrioles are also observed in Drosophila, Chlamydomonas, Tetrahymena, and Paramecium cep135 mutants (Table 2), and these results collectively suggest that the structural integrity of centrioles is compromised [144–150]. Since these structural anomalies are known to induce mitotic defects, including the formation of monopolar spindles, it would be interesting in the long run to investigate their consequences on prenatal neurogenesis [123, 143].

12. CEP152 (Centrosomal Protein of 152 kDa)

Although CEP152 is deficient in both MCPH and SCKL, mutations in CEP152 are by far the most common cause of SCKL, accounting for the majority of cases [27, 151]. During the early step of centriole duplication, CEP152 and its associated partner, CEP192 form a discrete ring around parental centrioles, making the site of PLK4 recruitment and nascent centriole assembly [107, 108, 152]. The centrosomal localization of CEP152 is also dependent on CEP192, but not vice versa. In addition, CEP152 is known to interact with CEP57 (centrosomal protein of 57 kDa) and CEP63 (centrosomal protein of 63 kDa), the latter of which is a SCKL protein [28, 153, 154]. While CEP152 and CEP63 are mutually dependent on one another for their centrosomal localization, only the former is absolutely required for centriole duplication, and a loss of this protein leads to severe mitotic defects and the formation of monopolar spindles [109–111]. In addition, CEP152 binds to CINP, a CDK2-interacting protein involved in DNA damage response and genome maintenance [151], thereby regulating cell cycle checkpoints. Indeed, centrosomes and nuclei show numerical and morphological abnormalities, indicative of aberrant cell division and cell cycle checkpoint, in CEP152-deficient patient fibroblasts/lymphocytes [151].

13. ZNF335 (Zinc Finger Protein 335)

ZNF335 is a nuclear protein and a novel component of the H3K4 methyltransferase complex involved in chromatin-remodelling and transcriptional regulation [155, 156]. One critical function of ZNF335 is its binding to the promoter region of REST/NRSF (RE1-silencing transcription factor/neuron-restrictive silencer factor), a master regulator of neuroprogenitor proliferation, and neuronal differentiation. Elegant studies using Znf335 deficient mice have demonstrated that this protein is required for many aspects of neurodevelopment, including neurogenesis and neuronal cell fate specification, morphogenesis, and differentiation (Table 2) [156]. Perhaps because of the multifaceted nature of ZNF335, its inactivation in humans leads to a more severe phenotype compared to most reported cases of microcephaly.

14. PHC1 (Polyhomeotic-Like Protein 1)

PHC1 belongs to a member of the polycomb group which modulates chromatin remodelling [157]. This protein localizes to the nucleus and functions as an E3 ubiquitin ligase to promote the ubiquitination of histone H2A and to regulate the levels of GEMININ, a protein that partially localizes to the centrosome and is involved in cell cycle control [158, 159]. Depletion of PHC1 induces aberrant DNA damage repair and polyploidy, again reinforcing the view that proteins involved in cell cycle regulation and/or checkpoints are critical for brain development [157].

15. CDK6 (Cyclin-Dependent Kinase 6)

Hussain and coworkers have recently identified mutations in a new gene that can cause MCPH. Interestingly, this gene encodes CDK6, a well-known member of the cyclin/cyclin-dependent kinase family crucial for cell cycle progression in G1 and S phases [29, 160]. Although several previous reports have shown that CDK6 exhibits both cytoplasmic and nuclear localization during interphase, this protein, like WDR62 and ASPM, becomes enriched at the spindle poles during mitosis [29, 161–163]. Ablation of CDK6 impairs cell polarity and induces supernumerary centrosomes and aneuploidy, but it is not clear whether these phenotypes arise from cell cycle and/or spindle pole defects [29]. Interestingly, Cdk6 knock-out mice are viable and develop normally (Table 2), suggesting that this protein is dispensable for proliferation in most cell types [164]. Paradoxically, a more recent study illustrates the importance of Cdk6 in embryonic neurogenesis and demonstrates that inactivation of Pax6, a transcription factor that directly represses the expression of Cdk6, leads to inappropriate activation of Cdk6 and overproliferation of neuroprogenitor cells in mice [165]. Another study also highlighted a role for CDK6 in the regulation of G1 length during adult neurogenesis, although its potential contribution to embryonic neurogenesis was not addressed [166].

16. A Multiprotein Complex in Brain Development

In summary, almost all MCPH proteins are linked to the centrosome with varying levels of intimacy (Figure 2). CENPJ, STIL, and CEP135 are core centriolar components; MICROCEPHALIN, CDK5RAP2, and CEP152 form an integral part of the PCM; WDR62, ASPM, and CDK6 are transiently associated with the centrosome; and two other microcephaly proteins, CASC5 and PHC1, interact with known centrosomal constituents. In addition, a handful of microcephaly proteins are physically linked to each other, either directly or indirectly, suggesting the existence of a large network of protein-protein interactions essential for prenatal neurogenesis. We believe that the loss of a single protein or protein-protein interaction could cripple the interaction network, thereby increasing susceptibility to disease. Tellingly, mutations in PERICENTRIN, a protein in the network that interacts with MICROCEPHALIN and CDK5RAP2, cause SCKL and primordial dwarfism [167]. Furthermore, upregulation of Plk4 is shown to impede brain development and cause microcephaly in mice, although there have been no reported cases in humans so far [168]. Moreover, CEP63 is a protein deficient in SCKL and known to interact with CEP152 [28]. As additional disease genes are being rapidly discovered, it is intriguing to speculate on their identity and whether they encode proteins in the interaction network.

Figure 2: Microcephaly protein interaction network. The majority of microcephaly proteins (red) are associated with centrosomes. CENPJ, STIL, and CEP135 are components of centrioles (green box), while MICROCEPHALIN, CDK5RAP2, and CEP152 are part of the PCM (orange background). WDR62, ASPM, and CDK6 temporarily localize to the PCM. In addition, CASC5 and PHC1 are known to interact with proteins at the centrosome. For ZNF335, its precise connection to the centrosome is not understood. Microcephaly proteins are physically linked to one another either directly or indirectly (solid black lines) to form a protein network.

17. Conclusion

During the past decade, substantial progress has been made in our understanding of brain development and the genetic basis of MCPH. It is now apparent that microcephaly proteins control a number of cellular processes, including centriole biogenesis, centrosome maturation, cell cycle and DNA damage checkpoint, spindle positioning, and mitosis, all of which impinge on brain growth and size (Figure 3). While neuronal homeostasis is thought to be maintained by a complex interplay between the opposing actions of cell proliferation and cell death, symmetric and asymmetric division, and/or normal and aberrant differentiation, to what extent does each of these contribute to brain development? Despite our knowledge of microcephaly proteins, many important questions remain. For instance, why do some proteins appear to have a better-defined role in regulating the switch between symmetric and asymmetric division in the developing brain, and why others are more frequently involved in SCKL and/or have additional functions in more than one cell/tissue type? Is the centrosome a central hub for coordinating and integrating various molecular events crucial for prenatal neurogenesis? We firmly believe that the answers to these questions hinge on our ability to fully understand the functional importance of each microcephaly protein and build upon the existing protein interaction network. These studies would help to better define microcephaly disorders and to facilitate early diagnosis and prognosis.

Figure 3: Cellular processes involved in microcephaly. A model depicting how malfunction of microcephaly proteins perturbs neurogenesis. A loss of microcephaly proteins can disturb various cellular processes, including chromatin remodelling, kinetochore integrity, centrosome biogenesis, or centrosome maturation, which impair cell cycle checkpoints and mitosis. These perturbations disrupt the equilibrium between cell proliferation and cell death, symmetric and asymmetric division, and/or normal and abnormal differentiation, reducing the total number of neuroprogenitor cells and differentiated neurons in the developing brain, leading to microcephaly.

Conflict of Interests

The authors have no conflict of interests to declare.

Acknowledgments

The authors wish to thank an anonymous reviewer for critical reading of the paper. William Y. Tsang was a Canadian Institutes of Health Research New Investigator and a Fonds de Recherche Santé Junior 1 Research Scholar. This work was supported by a Canadian Institutes of Health Research Grant (MOP-115033) and an IRCM-Emmanuel Triassi scholarship to Marine Barbelanne.

References

J. Cox, A. P. Jackson, J. Bond, and C. G. Woods, “What primary microcephaly can tell us about brain growth,” Trends in Molecular Medicine, vol. 12, no. 8, pp. 358–366, 2006.

S. Mahmood, W. Ahmad, and M. J. Hassan, “Autosomal recessive primary microcephaly (MCPH): clinical manifestations, genetic heterogeneity and mutation continuum,” Orphanet Journal of Rare Diseases, vol. 6, no. 1, article 39, 2011.

C. G. Woods and A. Parker, “Investigating microcephaly,” Archives of Disease in Childhood, vol. 98, no. 9, pp. 707–713, 2013.

C. G. Woods, J. Bond, and W. Enard, “Autosomal recessive primary microcephaly (MCPH): a review of clinical, molecular, and evolutionary findings,” The American Journal of Human Genetics, vol. 76, no. 5, pp. 717–728, 2005.

S. Passemard, A. M. Kaindl, and A. Verloes, “Microcephaly,” in Handbook of Clinical Neurology, vol. 111, pp. 129–141, 2013.

S. Passemard, L. Titomanlio, M. Elmaleh et al., “Expanding the clinical and neuroradiologic phenotype of primary microcephaly due to ASPM mutations,” Neurology, vol. 73, no. 12, pp. 962–969, 2009.

G. H. Mochida and C. A. Walsh, “Molecular genetics of human microcephaly,” Current Opinion in Neurology, vol. 14, no. 2, pp. 151–156, 2001.

C. Kerzendorfer, R. Colnaghi, I. Abramowicz, G. Carpenter, and M. O'Driscoll, “Meier-Gorlin syndrome and Wolf-Hirschhorn syndrome: two developmental disorders highlighting the importance of efficient DNA replication for normal development and neurogenesis,” DNA Repair, vol. 12, no. 8, pp. 637–644, 2013.

G. K. Thornton and C. G. Woods, “Primary microcephaly: do all roads lead to Rome?” Trends in Genetics, vol. 25, no. 11, pp. 501–510, 2009.

A. M. Kaindl, S. Passemard, P. Kumar et al., “Many roads lead to primary autosomal recessive microcephaly,” Progress in Neurobiology, vol. 90, no. 3, pp. 363–383, 2010.

A. Klingseisen and A. P. Jackson, “Mechanisms and pathways of growth failure in primordial dwarfism,” Genes and Development, vol. 25, no. 19, pp. 2011–2024, 2011.

M. O'Driscoll, A. P. Jackson, and P. A. Jeggo, “Microcephalin: a causal link between impaired damage response signalling and microcephaly,” Cell Cycle, vol. 5, no. 20, pp. 2339–2344, 2006.

A. P. Jackson, H. Eastwood, S. M. Bell et al., “Identification of microcephalin, a protein implicated in determining the size of the human brain,” The American Journal of Human Genetics, vol. 71, no. 1, pp. 136–142, 2002.

J. Bond, E. Roberts, G. H. Mochida et al., “ASPM is a major determinant of cerebral cortical size,” Nature Genetics, vol. 32, no. 2, pp. 316–320, 2002.

J. Bond, E. Roberts, K. Springell, et al., “A centrosomal mechanism involving CDK5RAP2 and CENPJ controls brain size,” Nature Genetics, vol. 37, pp. 353–355, 2005.

A. K. Nicholas, M. Khurshid, J. Désir et al., “WDR62 is associated with the spindle pole and is mutated in human microcephaly,” Nature Genetics, vol. 42, no. 11, pp. 1010–1014, 2010.

L. Issa, N. Kraemer, C. H. Rickert et al., “CDK5RAP2 expression during murine and human brain development correlates with pathology in primary autosomal recessive microcephaly,” Cerebral Cortex, vol. 23, no. 9, pp. 2245–2260, 2013.

W. B. Huttner and Y. Kosodo, “Symmetric versus asymmetric cell division during neurogenesis in the developing vertebrate central nervous system,” Current Opinion in Cell Biology, vol. 17, no. 6, pp. 648–657, 2005.

E. Peyre and X. Morin, “An oblique view on the role of spindle orientation in vertebrate neurogenesis,” Development Growth and Differentiation, vol. 54, no. 3, pp. 287–305, 2012.

E. Taverna, M. Gotz, and W. B. Huttner, “The cell biology of neurogenesis: toward an understanding of the development and evolution of the neocortex,” Annual Review of Cell and Developmental Biology, vol. 30, 2014.

J. L. Fish, C. Dehay, H. Kennedy, and W. B. Huttner, “Making bigger brains—the evolution of neural-progenitor-cell division,” Journal of Cell Science, vol. 121, no. 17, pp. 2783–2793, 2008.

X. Zhong, G. P. Pfeifer, and X. Xu, “Microcephalin encodes a centrosomal protein,” Cell Cycle, vol. 5, no. 4, pp. 457–458, 2006.

T. W. Yu, G. H. Mochida, D. J. Tischfield et al., “Mutations in WDR62, encoding a centrosome-associated protein, cause microcephaly with simplified gyri and abnormal cortical architecture,” Nature Genetics, vol. 42, no. 11, pp. 1015–1020, 2010.

X. Zhong, L. Liu, A. Zhao, G. P. Pfeifer, and X. Xu, “The abnormal spindle-like, microcephaly-associated (ASPM) gene encodes a centrosomal protein,” Cell Cycle, vol. 4, no. 9, pp. 1227–1229, 2005.

A. Kumar, S. C. Girimaji, M. R. Duvvari, and S. H. Blanton, “Mutations in STIL, encoding a pericentriolar and centrosomal protein, cause primary microcephaly,” The American Journal of Human Genetics, vol. 84, no. 2, pp. 286–290, 2008.

M. S. Hussain, S. M. Baig, S. Neumann et al., “A truncating mutation of CEP135 causes primary microcephaly and disturbed centrosomal function,” The American Journal of Human Genetics, vol. 90, no. 5, pp. 871–878, 2012.

D. L. Guernsey, H. Jiang, J. Hussin et al., “Mutations in centrosomal protein CEP152 in primary microcephaly families linked to MCPH4,” American Journal of Human Genetics, vol. 87, no. 1, pp. 40–51, 2010.

J.-H. Sir, A. R. Barr, A. K. Nicholas et al., “A primary microcephaly protein complex forms a ring around parental centrioles,” Nature Genetics, vol. 43, no. 11, pp. 1147–1153, 2011.

M. S. Hussain, S. M. Baig, S. Neumann et al., “CDK6 associates with the centrosome during mitosis and is mutated in a large pakistani family with primary microcephaly,” Human Molecular Genetics, vol. 22, no. 25, pp. 5199–5214, 2013.

I. B. Alieva and R. E. Uzbekov, “The centrosome is a polyfunctional multiprotein cell complex,” Biochemistry, vol. 73, no. 6, pp. 626–643, 2008.

M. Bornens, “The centrosome in cells and organisms,” Science, vol. 335, no. 6067, pp. 422–426, 2012.

A. Debec, W. Sullivan, and M. Bettencourt-Dias, “Centrioles: active players or passengers during mitosis?” Cellular and Molecular Life Sciences, vol. 67, no. 13, pp. 2173–2194, 2010.

E. A. Nigg and J. W. Raff, “Centrioles, centrosomes, and cilia in health and disease,” Cell, vol. 139, no. 4, pp. 663–678, 2009.

W. Y. Tsang and B. D. Dynlacht, “CP110 and its network of partners coordinately regulate cilia assembly,” Cilia, vol. 2, no. 1, article 9, 2013.

D. Hossain and W. Y. Tsang, “Centrosome dysfunction and senescence: coincidence or causality?” Journal of Aging Science, vol. 1, p. 113, 2013.

E. H. Hinchcliffe and G. Sluder, ““It takes two to tango”: understanding how centrosome duplication is regulated throughout the cell cycle,” Genes and Development, vol. 15, no. 10, pp. 1167–1181, 2001.

E. A. Nigg and T. Stearns, “The centrosome cycle: centriole biogenesis, duplication and inherent asymmetries,” Nature Cell Biology, vol. 13, no. 10, pp. 1154–1160, 2011.

R. E. Palazzo, J. M. Vogel, B. J. Schnackenberg, D. R. Hull, and X. Wu, “Centrosome maturation,” Current Topics in Developmental Biology, vol. 49, pp. 449–470, 1999.

C. W. Brownlee and G. C. Rogers, “Show me your license, please: deregulation of centriole duplication mechanisms that promote amplification,” Cellular and Molecular Life Sciences, vol. 70, no. 6, pp. 1021–1034, 2013.

A. P. Jackson, D. P. McHale, D. A. Campbell et al., “Primary autosomal recessive microcephaly (MCPH1) maps to chromosome 8p22-pter,” The American Journal of Human Genetics, vol. 63, no. 2, pp. 541–546, 1998.

T. Venkatesh and P. S. Suresh, “Emerging roles of MCPH1: expedition from primary microcephaly to cancer,” European Journal of Cell Biology, vol. 93, no. 3, pp. 98–105, 2014.

L. J. Jeffers, B. J. Coull, S. J. Stack, and C. G. Morrison, “Distinct BRCT domains in Mcph1/Brit1 mediate ionizing radiation-induced focus formation and centrosomal localization,” Oncogene, vol. 27, no. 1, pp. 139–144, 2008.

S.-Z. Yang, F.-T. Lin, and W.-C. Lin, “MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis,” EMBO Reports, vol. 9, no. 9, pp. 907–915, 2008.

G. Peng and S.-Y. Lin, “BRITI/MCPHI is a multifunctional DNA damage responsive protein mediating DNA repair-associated chromatin remodeling,” Cell Cycle, vol. 8, no. 19, pp. 3071–3072, 2009.

G. Peng, E.-K. Yim, H. Dai et al., “BRIT1/MCPH1 links chromatin remodelling to DNA damage response,” Nature Cell Biology, vol. 11, no. 7, pp. 865–872, 2009.

J. L. Wood, Y. Liang, K. Li, and J. Chen, “Microcephalin/MCPH1 associates with the condensin II complex to function in homologous recombination repair,” Journal of Biological Chemistry, vol. 283, no. 43, pp. 29586–29592, 2008.

M. Trimborn, D. Schindler, H. Neitzel, and T. Hirano, “Misregulated chromosome condensation in MCPH1 primary microcephaly is mediated by condensin II,” Cell Cycle, vol. 5, no. 3, pp. 322–326, 2006.

A. Tibelius, J. Marhold, H. Zentgraf et al., “Microcephalin and pericentrin regulate mitotic entry via centrosome-associated Chk1,” Journal of Cell Biology, vol. 185, no. 7, pp. 1149–1157, 2009.

R. Gruber, Z. Zhou, M. Sukchev, T. Joerss, P.-O. Frappart, and Z.-Q. Wang, “MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway,” Nature Cell Biology, vol. 13, no. 11, pp. 1325–1334, 2011.

Y. Liang, H. Gao, S.-Y. Lin et al., “BRIT1/MCPH1 is essential for mitotic and meiotic recombination DNA repair and maintaining genomic stability in mice,” PLoS Genetics, vol. 6, no. 1, Article ID e1000826, 2010.

M. Trimborn, M. Ghani, D. J. Walther et al., “Establishment of a mouse model with misregulated chromosome condensation due to defective Mcph1 function,” PLoS ONE, vol. 5, no. 2, Article ID e9242, 2010.

Z. W. Zhou, A. Tapias, C. Bruhn, R. Gruber, M. Sukchev, and Z. Q. Wang, “DNA damage response in microcephaly development of MCPH1 mouse model,” DNA Repair, vol. 12, no. 8, pp. 645–655, 2013.

K. Bilgüvar, A. K. Öztürk, A. Louvi et al., “Whole-exome sequencing identifies recessive WDR62 mutations in severe brain malformations,” Nature, vol. 467, no. 7312, pp. 207–210, 2010.

C. A. Bacino, L. A. Arriola, J. Wiszniewska, and P. E. Bonnen, “WDR62 missense mutation in a consanguineous family with primary microcephaly,” American Journal of Medical Genetics A, vol. 158, no. 3, pp. 622–625, 2012.

M. A. Bogoyevitch, Y. Y. C. Yeap, Z. Qu et al., “WD40-repeat protein 62 is a JNK-phosphorylated spindle pole protein required for spindle maintenance and timely mitotic progression,” Journal of Cell Science, vol. 125, no. 21, pp. 5096–5109, 2012.

H. G. Farag, S. Froehler, K. Oexle et al., “Abnormal centrosome and spindle morphology in a patient with autosomal recessive primary microcephaly type 2 due to compound heterozygous WDR62 gene mutation,” Orphanet Journal of Rare Diseases, vol. 8, no. 1, article 178, 2013.

R. A. MacCorkle-Chosnek, A. VanHooser, D. W. Goodrich, B. R. Brinkley, and T.-H. Tan, “Cell cycle regulation of c-Jun N-terminal kinase activity at the centrosomes,” Biochemical and Biophysical Research Communications, vol. 289, no. 1, pp. 173–180, 2001.

D. Xu, F. Zhang, Y. Wang, Y. Sun, and Z. Xu, “Microcephaly-associated protein WDR62 regulates neurogenesis through JNK1 in the developing neocortex,” Cell Reports, vol. 6, no. 1, pp. 104–116, 2014.

C. Novorol, J. Burkhardt, K. J. Wood et al., “Microcephaly models in the developing zebrafish retinal neuroepithelium point to an underlying defect in metaphase progression,” Open Biology, vol. 3, no. 10, Article ID 130065, 2013.

J.-F. Chen, Y. Zhang, J. Wilde, K. C. Hansen, F. Lai, and L. Niswander, “Microcephaly disease gene Wdr62 regulates mitotic progression of embryonic neural stem cells and brain size,” Nature Communications, vol. 5, article 3885, 2014.

V. Joukov, A. De Nicolo, A. Rodriguez, J. C. Walter, and D. M. Livingston, “Centrosomal protein of 192 kDa (Cep192) promotes centrosome-driven spindle assembly by engaging in organelle-specific Aurora A activation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 49, pp. 21022–21027, 2010.

K.-W. Fong, Y.-K. Choi, J. B. Rattner, and R. Z. Qi, “CDK5RAP2 is a pericentriolar protein that functions in centrosomal attachment of the γ-tubulin ring complex,” Molecular Biology of the Cell, vol. 19, no. 1, pp. 115–125, 2008.

Y.-K. Choi, P. Liu, S. K. Sze, C. Dai, and R. Z. Qi, “CDK5RAP2 stimulates microtubule nucleation by the γ-tubulin ring complex,” Journal of Cell Biology, vol. 191, no. 6, pp. 1089–1095, 2010.

K. Lee and K. Rhee, “PLK1 phosphorylation of pericentrin initiates centrosome maturation at the onset of mitosis,” Journal of Cell Biology, vol. 195, no. 7, pp. 1093–1101, 2011.

S. Kim and K. Rhee, “Importance of the CEP215-pericentrin interaction for centrosome maturation during mitosis,” PLoS ONE, vol. 9, no. 1, Article ID e87016, 2014.

T. L. Megraw, J. T. Sharkey, and R. S. Nowakowski, “Cdk5rap2 exposes the centrosomal root of microcephaly syndromes,” Trends in Cell Biology, vol. 21, no. 8, pp. 470–480, 2011.

J. A. Barrera, L.-R. Kao, R. E. Hammer, J. Seemann, J. L. Fuchs, and T. L. Megraw, “CDK5RAP2 regulates centriole engagement and cohesion in mice,” Developmental Cell, vol. 18, no. 6, pp. 913–926, 2010.

S. Graser, Y.-D. Stierhof, and E. A. Nigg, “Cep68 and Cep215 (Cdk5rap2) are required for centrosome cohesion,” Journal of Cell Science, vol. 120, no. 24, pp. 4321–4331, 2007.

X. Zhang, D. Liu, S. Lv et al., “CDK5RAP2 is required for spindle checkpoint function,” Cell Cycle, vol. 8, no. 8, pp. 1206–1216, 2009.

J. J. Buchman, H.-C. Tseng, Y. Zhou, C. L. Frank, Z. Xie, and L.-H. Tsai, “Cdk5rap2 interacts with pericentrin to maintain the neural progenitor pool in the developing neocortex,” Neuron, vol. 66, no. 3, pp. 386–402, 2010.

S. B. Lizarraga, S. P. Margossian, M. H. Harris et al., “Cdk5rap2 regulates centrosome function and chromosome segregation in neuronal progenitors,” Development, vol. 137, no. 11, pp. 1907–1917, 2010.

A. Genin, J. Desir, N. Lambert et al., “Kinetochore KMN network gene CASC5 mutated in primary microcephaly,” Human Molecular Genetics, vol. 21, no. 24, pp. 5306–5317, 2012.

I. M. Cheeseman, T. Hori, T. Fukagawa, and A. Desai, “KNL1 and the CENP-H/I/K complex coordinately direct kinetochore assembly in vertebrates,” Molecular Biology of the Cell, vol. 19, no. 2, pp. 587–594, 2008.

V. M. Bolanos-Garcia, T. Lischetti, D. Matak-Vinkovic, et al., “Structure of a Blinkin-BUBR1 complex reveals an interaction crucial for kinetochore-mitotic checkpoint regulation via an unanticipated binding Site,” Structure, vol. 19, no. 11-12, pp. 1691–1700, 2011.

V. Krenn, A. Wehenkel, X. Li, S. Santaguida, and A. Musacchio, “Structural analysis reveals features of the spindle checkpoint kinase Bub1-kinetochore subunit Knl1 interaction,” Journal of Cell Biology, vol. 196, no. 4, pp. 451–467, 2012.

T. Kiyomitsu, C. Obuse, and M. Yanagida, “Human Blinkin/AF15q14 is required for chromosome alignment and the mitotic checkpoint through direct interaction with Bub1 and BubR1,” Developmental Cell, vol. 13, no. 5, pp. 663–676, 2007.

D. Varma and E. D. Salmon, “The KMN protein network—Chief conductors of the kinetochore orchestra,” Journal of Cell Science, vol. 125, no. 24, pp. 5927–5936, 2012.

J. Bond, S. Scott, D. J. Hampshire et al., “Protein-truncating mutations in ASPM cause variable reduction in brain size,” The American Journal of Human Genetics, vol. 73, no. 5, pp. 1170–1177, 2003.

A. Kumar, S. H. Blanton, M. Babu, M. Markandaya, and S. C. Girimaji, “Genetic analysis of primary microcephaly in Indian families: novel ASPM mutations,” Clinical Genetics, vol. 66, no. 4, pp. 341–348, 2004.

B. Pichon, S. Vankerckhove, G. Bourrouillou, L. Duprez, and M. J. Abramowicz, “A translocation breakpoint disrupts the ASPM gene in a patient with primary microcephaly,” European Journal of Human Genetics, vol. 12, no. 5, pp. 419–421, 2004.

J. Shen, W. Eyaid, G. H. Mochida et al., “ASPM mutations identified in patients with primary microcephaly and seizures,” Journal of Medical Genetics, vol. 42, no. 9, pp. 725–729, 2005.

A. Gul, M. J. Hassan, S. Mahmood et al., “Genetic studies of autosomal recessive primary microcephaly in 33 Pakistani families: novel sequence variants in ASPM gene,” Neurogenetics, vol. 7, no. 2, pp. 105–110, 2006.

A. Gul, M. Tariq, M. N. Khan, M. J. Hassan, G. Ali, and W. Ahmad, “Novel protein-truncating mutations in the ASPM gene in families with autosomal recessive primary microcephaly,” Journal of Neurogenetics, vol. 21, no. 3, pp. 153–163, 2007.

J. Desir, M. Cassart, P. David, P. van Bogaert, and M. Abramowicz, “Primary microcephaly with ASPM mutation shows simplified cortical gyration with antero-posterior gradient pre- and post-natally,” The American Journal of Medical Genetics Part A, vol. 146, no. 11, pp. 1439–1443, 2008.

F. Muhammad, S. M. Baig, L. Hansen et al., “Compound heterozygous aspm mutations in pakistani MCPH families,” The American Journal of Medical Genetics Part A, vol. 149, no. 5, pp. 926–930, 2009.

A. K. Nicholas, E. A. Swanson, J. J. Cox et al., “The molecular landscape of ASPM mutations in primary microcephaly,” Journal of Medical Genetics, vol. 46, no. 4, pp. 249–253, 2009.

A. Saadi, G. Borck, N. Boddaert et al., “Compound heterozygous ASPM mutations associated with microcephaly and simplified cortical gyration in a consanguineous Algerian family,” European Journal of Medical Genetics, vol. 52, no. 4, pp. 180–184, 2009.

H. Darvish, S. Esmaeeli-Nieh, G. B. Monajemi et al., “A clinical and molecular genetic study of 112 Iranian families with primary microcephaly,” Journal of Medical Genetics, vol. 47, no. 12, pp. 823–828, 2010.

R. Kousar, H. Nawaz, M. Khurshid et al., “Mutation analysis of the ASPM gene in 18 Pakistani families with autosomal recessive primary microcephaly,” Journal of Child Neurology, vol. 25, no. 6, pp. 715–720, 2010.

C. R. Jamieson, J.-P. Fryns, J. Jacobs, G. Matthijs, and M. J. Abramowicz, “Primary autosomal recessive microcephaly: MCPH5 maps to 1q25-q32,” The American Journal of Human Genetics, vol. 67, no. 6, pp. 1575–1577, 2000.

W. Y. Tsang, A. Spektor, D. J. Luciano et al., “CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability,” Molecular Biology of the Cell, vol. 17, no. 8, pp. 3423–3434, 2006.

J. Higgins, C. Midgley, A. M. Bergh et al., “Human ASPM participates in spindle organisation, spindle orientation and cytokinesis,” BMC Cell Biology, vol. 11, article 85, 2010.

J. L. Fish, Y. Kosodo, W. Enard, S. Paabo, and W. B. Huttner, “Aspm specifically maintains symmetric proliferative divisions of neuroepithelial cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 27, pp. 10438–10443, 2006.

C. Gonzalez, R. D. C. Saunders, J. Casal et al., “Mutations at the asp locus of Drosophila lead to multiple free centrosomes in syncytial embryos, but restrict centrosome duplication in larval neuroblasts,” Journal of Cell Science, vol. 96, no. 4, pp. 605–616, 1990.

M. G. Riparbelli, G. Callaini, D. M. Glover, and M. do Carmo Avides, “A requirement for the abnormal spindle protein to organise microtubules of the central spindle for cytokinesis in Drosophila,” Journal of Cell Science, vol. 115, no. 5, pp. 913–922, 2002.

J. N. Pulvers, J. Bryk, J. L. Fish et al., “Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 38, pp. 16595–16600, 2010.

J. Casal, C. Gonzalez, F. Wandosell, J. Avila, and P. Ripoll, “Abnormal meiotic spindles cause a cascade of defects during spermatogenesis in asp males of Drosophila,” Development, vol. 108, no. 2, pp. 251–260, 1990.

A. Fujimori, K. Itoh, S. Goto et al., “Disruption of Aspm causes microcephaly with abnormal neuronal differentiation,” Brain and Development, vol. 36, no. 8, pp. 661–669, 2014.

X.-L. Xu, W. Ma, Y.-B. Zhu et al., “The microtubule-associated protein ASPM regulates spindle assembly and meiotic progression in mouse oocytes,” PLoS ONE, vol. 7, no. 11, Article ID e49303, 2012.

N. Kouprina, A. Pavlicek, N. K. Collins et al., “The microcephaly ASPM gene is expressed in proliferating tissues and encodes for a mitotic spindle protein,” Human Molecular Genetics, vol. 14, no. 15, pp. 2155–2165, 2005.

C. Hagemann, J. Anacker, S. Gerngras et al., “Expression analysis of the autosomal recessive primary microcephaly genes MCPH1 (microcephalin) and MCPH5 (ASPM, abnormal spindle-like, microcephaly associated) in human malignant gliomas,” Oncology Reports, vol. 20, no. 2, pp. 301–308, 2008.

S.-Y. Lin, H.-W. Pan, S.-H. Liu et al., “ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma,” Clinical Cancer Research, vol. 14, no. 15, pp. 4814–4820, 2008.

R. Alsiary, A. Brüning-Richardson, J. Bond, E. E. Morrison, N. Wilkinson, and S. M. Bell, “Deregulation of microcephalin and ASPM expression are correlated with epithelial ovarian cancer progression,” PLoS ONE, vol. 9, no. 5, Article ID e97059, 2014.

P. Gönczy, “Towards a molecular architecture of centriole assembly,” Nature Reviews Molecular Cell Biology, vol. 13, no. 7, pp. 425–435, 2012.

S. Leidel and P. Gönczy, “Centrosome duplication and nematodes: recent insights from an old relationship,” Developmental Cell, vol. 9, no. 3, pp. 317–325, 2005.

J. Kleylein-Sohn, J. Westendorf, M. le Clech, R. Habedanck, Y.-D. Stierhof, and E. A. Nigg, “Plk4-induced centriole biogenesis in human cells,” Developmental Cell, vol. 13, no. 2, pp. 190–202, 2007.

K. F. Sonnen, A. M. Gabryjonczyk, E. Anselm, E. A. Nigg, and Y. D. Stierhof, “Human cep192 and cep152 cooperate in plk4 recruitment and centriole duplication,” Journal of Cell Science, vol. 126, no. 14, pp. 3223–3233, 2013.

T.-S. Kim, J.-E. Park, A. Shukla et al., “Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 50, pp. E4849–E4857, 2013.

E. M. Hatch, A. Kulukian, A. J. Holland, D. W. Cleveland, and T. Stearns, “Cep152 interacts with Plk4 and is required for centriole duplication,” Journal of Cell Biology, vol. 191, no. 4, pp. 721–729, 2010.

O. Cizmecioglu, M. Arnold, R. Bahtz et al., “Cep152 acts as a scaffold for recruitment of Plk4 and CPAP to the centrosome,” Journal of Cell Biology, vol. 191, no. 4, pp. 731–739, 2010.

N. S. Dzhindzhev, Q. D. Yu, K. Weiskopf et al., “Asterless is a scaffold for the onset of centriole assembly,” Nature, vol. 467, no. 7316, pp. 714–718, 2010.

M. van Breugel, M. Hirono, A. Andreeva et al., “Structures of SAS-6 suggest its organization in centrioles,” Science, vol. 331, no. 6021, pp. 1196–1199, 2011.

D. Kitagawa, I. Vakonakis, N. Olieric et al., “Structural basis of the 9-fold symmetry of centrioles,” Cell, vol. 144, no. 3, pp. 364–375, 2011.

R. Qiao, G. Cabral, M. M. Lettman, A. Dammermann, and G. Dong, “SAS-6 coiled-coil structure and interaction with SAS-5 suggest a regulatory mechanism in C. elegans centriole assembly,” The EMBO Journal, vol. 31, no. 22, pp. 4334–4347, 2012.

M. Lettman, Y. Wong, V. Viscardi et al., “Direct binding of SAS-6 to ZYG-1 recruits SAS-6 to the mother centriole for cartwheel assembly,” Developmental Cell, vol. 25, no. 3, pp. 284–298, 2013.

M. Delattre, C. Canard, and P. Gönczy, “Sequential protein recruitment in C. elegans centriole formation,” Current Biology, vol. 16, no. 18, pp. 1844–1849, 2006.

L. Pelletier, E. O’Toole, A. Schwager, A. A. Hyman, and T. Müller-Reichert, “Centriole assembly in Caenorhabditis elegans,” Nature, vol. 444, no. 7119, pp. 619–623, 2006.

C. J. C. Tang, S. Y. Lin, W. B. Hsu et al., “The human microcephaly protein STIL interacts with CPAP and is required for procentriole formation,” The EMBO Journal, vol. 30, no. 23, pp. 4790–4804, 2011.

L.-Y. Hung, H.-L. Chen, C.-W. Chang, B.-R. Li, and T. K. Tang, “Identification of a novel microtubule-destabilizing motif in CPAP that binds to tubulin heterodimers and inhibits microtubule assembly,” Molecular Biology of the Cell, vol. 15, no. 6, pp. 2697–2706, 2004.

W.-B. Hsu, L.-Y. Hung, C.-J. C. Tang, C.-L. Su, Y. Chang, and T. K. Tang, “Functional characterization of the microtubule-binding and -destabilizing domains of CPAP and d-SAS-4,” Experimental Cell Research, vol. 314, no. 14, pp. 2591–2602, 2008.

D. Comartin, G. D. Gupta, E. Fussner et al., “CEP120 and SPICE1 cooperate with CPAP in centriole elongation,” Current Biology, vol. 23, no. 14, pp. 1360–1366, 2013.

Y.-N. Lin, C.-T. Wu, Y.-C. Lin et al., “CEP120 interacts with CPAP and positively regulates centriole elongation,” Journal of Cell Biology, vol. 202, no. 2, pp. 211–219, 2013.

Y. C. Lin, C. W. Chang, W. B. Hsu et al., “Human microcephaly protein CEP135 binds to hSAS-6 and CPAP, and is required for centriole assembly,” The EMBO Journal, vol. 32, no. 8, pp. 1141–1154, 2013.

C.-J. C. Tang, R.-H. Fu, K.-S. Wu, W.-B. Hsu, and T. K. Tang, “CPAP is a cell-cycle regulated protein that controls centriole length,” Nature Cell Biology, vol. 11, no. 7, pp. 825–831, 2009.

T. I. Schmidt, J. Kleylein-Sohn, J. Westendorf et al., “Control of centriole length by CPAP and CP110,” Current Biology, vol. 19, no. 12, pp. 1005–1011, 2009.

G. Kohlmaier, J. Lončarek, X. Meng et al., “Overly long centrioles and defective cell division upon excess of the SAS-4-related protein CPAP,” Current Biology, vol. 19, no. 12, pp. 1012–1018, 2009.

J.-H. Cho, C.-J. Chang, C.-Y. Chen, and T. K. Tang, “Depletion of CPAP by RNAi disrupts centrosome integrity and induces multipolar spindles,” Biochemical and Biophysical Research Communications, vol. 339, no. 3, pp. 742–747, 2006.

J. Gopalakrishnan, V. Mennella, S. Blachon et al., “Sas-4 provides a scaffold for cytoplasmic complexes and tethers them in a centrosome,” Nature Communications, vol. 2, article 359, 2011.

L.-Y. Hung, C.-J. C. Tang, and T. K. Tang, “Protein 4.1 R-135 interacts with a novel centrosomal protein (CPAP) which is associated with the γ-tubulin complex,” Molecular and Cellular Biology, vol. 20, no. 20, pp. 7813–7825, 2000.

J. Gopalakrishnan, Y.-C. Chim, A. Ha et al., “Tubulin nucleotide status controls Sas-4-dependent pericentriolar material recruitment,” Nature Cell Biology, vol. 14, no. 8, pp. 865–873, 2012.

L. Shi, Q. Lin, and B. Su, “Human-specific hypomethylation of CENPJ, a key brain size regulator,” Molecular Biology and Evolution, vol. 31, no. 3, pp. 594–604, 2014.

R. E. McIntyre, P. L. Chavali, O. Ismail et al., “Disruption of mouse Cenpj, a regulator of centriole biogenesis, phenocopies Seckel syndrome,” PLoS Genetics, vol. 8, no. 11, Article ID e1003022, 2012.

S. Ladha, “Step to CEP152: uncovering a new mutation implicated in Seckel syndrome,” Clinical Genetics, vol. 79, no. 5, pp. 428–430, 2011.

J. Vulprecht, A. David, A. Tibelius et al., “STIL is required for centriole duplication in human cells,” Journal of Cell Science, vol. 125, no. 5, pp. 1353–1362, 2012.

C. Arquint, K. F. Sonnen, Y.-D. Stierhof, and E. A. Nigg, “Cell-cycle-regulated expression of STIL controls centriole number in human cells,” Journal of Cell Science, vol. 125, no. 5, pp. 1342–1352, 2012.

R. Habedanck, Y.-D. Stierhof, C. J. Wilkinson, and E. A. Nigg, “The Polo kinase Plk4 functions in centriole duplication,” Nature Cell Biology, vol. 7, no. 11, pp. 1140–1146, 2005.

S. Leidel, M. Delattre, L. Cerutti, K. Baumer, and P. Gönczy, “SAS-6 defines a protein family required for centrosome duplication in C. elegans and in human cells,” Nature Cell Biology, vol. 7, no. 2, pp. 115–125, 2005.

D. Kitagawa, G. Kohlmaier, D. Keller et al., “Spindle positioning in human cells relies on proper centriole formation and on the microcephaly proteins CPAP and STIL,” Journal of Cell Science, vol. 124, no. 22, pp. 3884–3893, 2011.

K. L. Pfaff, C. T. Straub, K. Chiang, D. M. Bear, Y. Zhou, and L. I. Zon, “The zebra fish cassiopeia mutant reveals that SIL is required for mitotic spindle organization,” Molecular and Cellular Biology, vol. 27, no. 16, pp. 5887–5897, 2007.

S. Izraeli, L. A. Lowe, V. L. Bertness et al., “The SIL gene is required for mouse embryonic axial development and left-right specification,” Nature, vol. 399, no. 6737, pp. 691–694, 1999.

K. Kim, S. Lee, J. Chang, and K. Rhee, “A novel function of CEP135 as a platform protein of C-NAP1 for its centriolar localization,” Experimental Cell Research, vol. 314, no. 20, pp. 3692–3700, 2008.

A. Kumar, V. Rajendran, R. Sethumadhavan, and R. Purohit, “CEP proteins: the knights of centrosome dynasty,” Protoplasma, vol. 250, no. 5, pp. 965–983, 2013.

B. Inanç, M. Pütz, P. Lalor et al., “Abnormal centrosomal structure and duplication in Cep135-deficient vertebrate cells,” Molecular Biology of the Cell, vol. 24, no. 17, pp. 2645–2654, 2013.

Z. Carvalho-Santos, P. Machado, I. Alvarez-Martins et al., “BLD10/CEP135 is a microtubule-associated protein that controls the formation of the flagellum central microtubule pair,” Developmental Cell, vol. 23, no. 2, pp. 412–424, 2012.

H. Roque, A. Wainman, J. Richens, K. Kozyrska, A. Franz, and J. W. Raff, “Drosophila Cep135/Bld10 maintains proper centriole structure but is dispensable for cartwheel formation,” Journal of Cell Science, vol. 125, no. 23, pp. 5881–5886, 2012.

K. Matsuura, P. A. Lefebvre, R. Kamiya, and M. Hirono, “Bld10p, a novel protein essential for basal body assembly in Chlamydomonas: localization to the cartwheel, the first ninefold symmetrical structure appearing during assembly,” Journal of Cell Biology, vol. 165, no. 5, pp. 663–671, 2004.

M. Hiraki, Y. Nakazawa, R. Kamiya, and M. Hirono, “Bld10p constitutes the cartwheel-spoke tip and stabilizes the 9-fold symmetry of the centriole,” Current Biology, vol. 17, no. 20, pp. 1778–1783, 2007.

M. Jerka-Dziadosz, D. Gogendeau, C. Klotz, J. Cohen, J. Beisson, and F. Koll, “Basal body duplication in paramecium: the key role of Bld10 in assembly and stability of the Cartwheel,” Cytoskeleton, vol. 67, no. 3, pp. 161–171, 2010.

B. A. Bayless, T. H. Giddings Jr., M. Winey, and C. G. Pearson, “Bld10/Cep135 stabilizes basal bodies to resist cilia-generated forces,” Molecular Biology of the Cell, vol. 23, no. 24, pp. 4820–4832, 2012.

V. Mottier-Pavie and T. L. Megraw, “Drosophila Bld10 is a centriolar protein that regulates centriole, basal body, and motile cilium assembly,” Molecular Biology of the Cell, vol. 20, no. 10, pp. 2605–2614, 2009.

E. Kalay, G. Yigit, Y. Aslan et al., “CEP152 is a genome maintenance protein disrupted in Seckel syndrome,” Nature Genetics, vol. 43, no. 1, pp. 23–26, 2011.

T. Avidor-Reiss and J. Gopalakrishnan, “Building a centriole,” Current Opinion in Cell Biology, vol. 25, no. 1, pp. 72–77, 2013.

N. J. Brown, M. Marjanovic, J. Lüders, T. H. Stracker, and V. Costanzo, “Cep63 and cep152 cooperate to ensure centriole duplication,” PLoS ONE, vol. 8, no. 7, Article ID e69986, 2013.

G. Lukinavičius, D. Lavogina, M. Orpinell et al., “Selective chemical crosslinking reveals a Cep57-Cep63-Cep152 centrosomal complex,” Current Biology, vol. 23, no. 3, pp. 265–270, 2013.

S. Garapaty, C.-F. Xu, P. Trojer, M. A. Mahajan, T. A. Neubert, and H. H. Samuels, “Identification and characterization of a novel nuclear protein complex involved in nuclear hormone receptor-mediated gene regulation,” The Journal of Biological Chemistry, vol. 284, no. 12, pp. 7542–7552, 2009.

Y. J. Yang, A. E. Baltus, R. S. Mathew et al., “Microcephaly gene links trithorax and REST/NRSF to control neural stem cell proliferation and differentiation,” Cell, vol. 151, no. 5, pp. 1097–1112, 2012.

S. Awad, M. S. Al-Dosari, N. Al-Yacoub et al., “Mutation in PHC1 implicates chromatin remodeling in primary microcephaly pathogenesis,” Human Molecular Genetics, vol. 22, no. 11, pp. 2200–2213, 2013.

K.-E. K. Tachibana, M. A. Gonzalez, G. Guarguaglini, E. A. Nigg, and R. A. Laskey, “Depletion of licensing inhibitor geminin causes centrosome overduplication and mitotic defects,” EMBO Reports, vol. 6, no. 11, pp. 1052–1057, 2005.

F. Lu, R. Lan, H. Zhang, Q. Jiang, and C. Zhang, “Geminin is partially localized to the centrosome and plays a role in proper centrosome duplication,” Biology of the Cell, vol. 101, no. 5, pp. 273–285, 2009.

C. Bertoli, J. M. Skotheim, and R. A. M. de Bruin, “Control of cell cycle transcription during G1 and S phases,” Nature Reviews Molecular Cell Biology, vol. 14, no. 8, pp. 518–528, 2013.

D. Mahony, D. A. Parry, and E. Lees, “Active cdk6 complexes are predominantly nuclear and represent only a minority of the cdk6 in T cells,” Oncogene, vol. 16, no. 5, pp. 603–611, 1998.

D. M. Kohrt, J. I. Crary, V. Gocheva, P. W. Hinds, and M. J. Grossel, “Distinct subcellular distribution of cyclin dependent kinase 6,” Cell Cycle, vol. 8, no. 17, pp. 2837–2843, 2009.

T. K. Kwon, M. A. Buchholz, E. W. Gabrielson, and A. A. Nordin, “A novel cytoplasmic substrate for cdk4 and cdk6 in normal and malignant epithelial derived cells,” Oncogene, vol. 11, no. 10, pp. 2077–2083, 1995.

M. Malumbres, R. Sotillo, D. Santamaría et al., “Mammalian cells cycle without the D-type cyclin-dependent kinases Cdk4 and Cdk6,” Cell, vol. 118, no. 4, pp. 493–504, 2004.

D. Mi, C. Carr, P. A. Georgala et al., “Pax6 Exerts regional control of cortical progenitor proliferation via direct repression of Cdk6 and Hypophosphorylation of pRb,” Neuron, vol. 78, no. 2, pp. 269–284, 2013.

P. Beukelaers, R. Vandenbosch, N. Caron et al., “Cdk6-dependent regulation of G1 length controls adult neurogenesis,” Stem Cells, vol. 29, no. 4, pp. 713–724, 2011.

A. Rauch, C. T. Thiel, D. Schindler et al., “Mutations in the pericentrin (PCNT) gene cause primordial dwarfism,” Science, vol. 319, no. 5864, pp. 816–819, 2008.

V. Marthiens, M. A. Rujano, C. Pennetier, S. Tessier, P. Paul-Gilloteaux, and R. Basto, “Centrosome amplification causes microcephaly,” Nature Cell Biology, vol. 15, no. 7, pp. 731–740, 2013.

E. Roberts, A. P. Jackson, A. C. Carradice et al., “The second locus for autosomal recessive primary microcephaly (MCPH2) maps to chromosome 19q13.1-13.2,” European Journal of Human Genetics, vol. 7, no. 7, pp. 815–820, 1999.

L. Moynihan, A. P. Jackson, E. Roberts et al., “A third novel locus for primary autosomal recessive microcephaly maps to chromosome 9q34,” The American Journal of Human Genetics, vol. 66, no. 2, pp. 724–727, 2000.

C. R. Jamieson, C. Govaerts, and M. J. Abramowicz, “Primary autosomal recessive microcephaly: homozygosity mapping of MCPH4 to chromosome 15,” The American Journal of Human Genetics, vol. 65, no. 5, pp. 1465–1469, 1999.

L. Pattison, Y. J. Crow, V. J. Deeble et al., “A fifth locus for primary autosomal recessive microcephaly maps to chromosome 1q31,” American Journal of Human Genetics, vol. 67, no. 6, pp. 1578–1580, 2000.